ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,090,264 | +172.7% | 100,306 | +214.4% | 0.00% | +200.0% |
Q2 2023 | $766,515 | +66.1% | 31,909 | +29.3% | 0.00% | 0.0% |
Q1 2023 | $461,388 | +31.8% | 24,675 | +12.2% | 0.00% | 0.0% |
Q4 2022 | $350,000 | -7.2% | 21,986 | -4.3% | 0.00% | 0.0% |
Q3 2022 | $377,000 | +17.1% | 22,984 | +0.5% | 0.00% | 0.0% |
Q2 2022 | $322,000 | -33.2% | 22,875 | -3.4% | 0.00% | 0.0% |
Q1 2022 | $482,000 | -22.6% | 23,675 | -10.6% | 0.00% | 0.0% |
Q4 2021 | $623,000 | +54.6% | 26,485 | +10.0% | 0.00% | 0.0% |
Q3 2021 | $403,000 | -36.0% | 24,086 | -6.2% | 0.00% | 0.0% |
Q2 2021 | $630,000 | -9.6% | 25,679 | -4.7% | 0.00% | -50.0% |
Q1 2021 | $697,000 | -56.1% | 26,946 | -9.4% | 0.00% | -50.0% |
Q4 2020 | $1,589,000 | +20.3% | 29,752 | -3.9% | 0.00% | 0.0% |
Q3 2020 | $1,321,000 | +11.9% | 30,968 | +27.0% | 0.00% | 0.0% |
Q2 2020 | $1,180,000 | +16.5% | 24,375 | +2.3% | 0.00% | 0.0% |
Q1 2020 | $1,013,000 | – | 23,830 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |